Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the top most undervalued biotech stocks to buy now. Guggenheim ...

A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed ...

Sanofi (SNY) halts shipments of cholesterol drug Praluent developed with Regeneron (REGN) due to availability issues. Read ...

"Donald Trump's shocking press conference exit sparks viral health speculation. What really happened? #TrumpHealthMystery" ...

In May 2025, the Company reported additional long-term data from its nonhuman primate (“NHP”) study that demonstrated durable and consistent FVIII activity levels through approximately 19 months. Mean ...

Veru Inc. ( NASDAQ: VERU) Q3 2025 Earnings Call August 12, 2025 8:00 AM ET K. Gary Barnette - Chief Scientific Officer Michael J. Purvis - Executive VP, General Counsel & Corporate Strategy and ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline ...

Lyten buys assets out of Northvolt bankruptcy, Pemex plans big petrochemical investments, New York to get major chlorhexidine ...

A team of Latham & Watkins litigators, including a recent recruit from Cravath Swaine & Moore, are now representing ...